Mission and History
Accelerated Cure Project (ACP) is a non-profit organization dedicated to accelerating research efforts to improve diagnosis, to optimize treatment and to cure multiple sclerosis.
ACP believes that research is the only way to greatly improve the outlook for people with MS. We work in collaboration with all MS stakeholders, including those living with MS, caregivers, researchers, clinicians, funders, and others, to develop centralized resources and to make those readily available to scientists around the world. Since our founding in 2001 by a person living with MS, we have been committed to facilitating and accelerating MS research and to providing researchers with access to the biospecimens, data, and people they need to conduct their work.
Our offerings include:
- The ACP Repository: A collection of highly characterized biosamples and data from over 3,200 subjects, available to any scientists conducting research that can positively impact people with MS
- iConquerMS™: A people-powered research network of more than 8,500 people affected by the disease who are interested in sharing their insights, health information, and lived experience to drive research forward on the topics that matter most to them.
- Inclusive Engagement Resources: Our MS Minority Research Engagement Partnership Network and our Research Inclusion Diversity and Equity Council are two of our resources aimed at understanding and eliminating the barriers to participation in research for those from historically marginalized populations.
ACP’s efforts are guided by the priorities and needs of those affected by MS. We believe that the voices of those diagnosed with the disease and their caregivers should be central at all phases of research, from the questions to be asked, through the design of studies and the selection of success measures, through to dissemination for impact. Our collaborative approach brings together experts — those with lived experience, the health care providers who care for them, and the scientists studying MS, to develop and deploy solutions to improve the health, healthcare, and quality of life for all affected by MS.
